Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis

Clinical trial NCT03463187 · COMPLETED

Trial details

NCT number: NCT03463187
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Moderate-to-severe Chronic Plaque Psoriasis

Start date: 2017-12-15
Primary completion: 2020-08-31
Enrollment: 211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.